On May, 1 The EPS for Novo Nordisk A/S (NVO) Expected At $0.63

Novo Nordisk A/S (NYSE:NVO) Corporate Logo

Novo Nordisk A/S (NYSE:NVO) is awaited to reveal earnings on May, 1., as reported by Faxor. earnings per share of $0.63 is 13.70 % down from 2018’s $0.73 EPS. If reported the P/E will be 20.14 with $1.50 billion profit. Wall Street now predicts 16.67 % EPS growth despite Novo Nordisk A/S last quarter’s EPS of $0.54. NVO is touching $50.76 during the last trading session, after increased 0.40%.Currently Novo Nordisk A/S is downtrending after 2.11% change in last April 8, 2018. NVO has 763,390 shares volume. The stock underperformed the S&P500 by 6.48%.

Novo Nordisk A/S (NYSE:NVO) Ratings Coverage

In total 6 analysts cover Novo Nordisk (NYSE:NVO). “Buy” rating has 3, “Sell” are 0, while 3 are “Hold”. 50% are bullish. 11 are the (NYSE:NVO)’s analyst reports since October 8, 2018 according to StockzIntelligence Inc. On Monday, November 19 the firm has “Overweight” rating by JP Morgan given. On Tuesday, December 11 the stock has “Hold” rating by Jefferies. On Monday, October 8 the firm earned “Neutral” rating by Bank of America.

Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide.The company has $121.19 billion market cap. It operates in two divisions, Diabetes and Obesity Care, and Biopharmaceuticals.The P/E ratio is 20.62. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles.

A couple more Novo Nordisk A/S (NYSE:NVO) news were released by: Seekingalpha.com which released on April 06, 2019 “Stocks To Watch: Disney+ And Bank Majors Step Out – Seeking Alpha”, also Seekingalpha.com on March 25, 2019 released “Novo’s oral semaglutide beats Merck’s Januvia in late-stage study – Seeking Alpha”, the next Investingnews.com is “Catalyst Biosciences Rises on European Orphan Designation | INN – Investing News Network” on April 02, 2019. Gurufocus.com has article titled “6 Stocks Growing Earnings – GuruFocus.com”.

Novo Nordisk A/S (NYSE:NVO) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.